↓ Skip to main content

Cochrane Database of Systematic Reviews

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, February 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
18 X users
facebook
1 Facebook page

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
73 Mendeley
Title
Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer
Published in
Cochrane database of systematic reviews, February 2022
DOI 10.1002/14651858.cd012007.pub2
Pubmed ID
Authors

Natalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, Boon Cher Goh, Ruby Yun-Ju Huang, Yu Yang Soon, Elizabeth James, Adrian Cook, Andrew Clamp, David Sp Tan

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 13 18%
Other 7 10%
Student > Bachelor 5 7%
Student > Ph. D. Student 4 5%
Student > Master 4 5%
Other 4 5%
Unknown 36 49%
Readers by discipline Count As %
Unspecified 13 18%
Medicine and Dentistry 11 15%
Nursing and Health Professions 5 7%
Psychology 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Other 3 4%
Unknown 38 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2023.
All research outputs
#2,055,562
of 25,391,701 outputs
Outputs from Cochrane database of systematic reviews
#4,331
of 11,487 outputs
Outputs of similar age
#49,618
of 451,317 outputs
Outputs of similar age from Cochrane database of systematic reviews
#55
of 87 outputs
Altmetric has tracked 25,391,701 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.9. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,317 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.